Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Aleta Biotherapeutics to Present at Society for Immunotherapy of Cancer

Aleta Biotherapeutics, a privately held immuno-oncology company focused on transforming cellular therapeutics to allow a broad spectrum of cancer indications to be targeted, today announced a poster presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting, to be held in Washington, D.C. and in a virtual platform on November 10-14, 2021.

Full details of the poster presentation are listed below:

Title: Evaluation and development of dual and triple antigen targeting CAR-T Engager proteins for Her2-positive CNS metastases and solid tumors
Presenter: Paul D. Rennert, PhD
Date & Time: Available 7 a.m. EST on Friday, November 12, 2021
Poster Session: Cellular Therapies
Abstract Number: 160

About Aleta Biotherapeutics

Our mission is to create cell therapeutics that provide robust and durable clinical benefit for patients suffering from advanced hematologic cancers and refractory solid tumors. Aleta's CAR-T Engager technology incorporates potent multi-antigen targeting, optimal T cell fitness, and persistence to aggressively attack cancers. We use this technology to build programs that solve specific clinical issues, including cell therapy relapses due to antigen loss and the challenge of overcoming solid tumor heterogeneity. Our lead development program has won landmark clinical support from Cancer Research UK and will enter Phase1/2 trials in 2022. To discover more about our mission, technologies and pipeline please visit www.aletabio.com.

These press releases may also interest you

at 14:48
Completing a successful $980,000 round of financing, AMNESIA Media today announced the launch of its effortlessly compliant software client HIGHLYTE, the first platform to use artificial intelligence to ensure social media safety in the highly...

at 14:47
England Logistics, one of the nation's top freight brokerage firms, announced it has been named to the 2021 Inc. 5000 list of the nation's fastest-growing private companies. The list represents a unique look at the most successful companies within...

at 14:45
The "Aptamers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global aptamers market reached a value of US$ 4.3 Billion in 2020. Looking...

at 14:40
Sound Life Sciences, a pioneer in contactless respiratory monitoring with its proprietary sonar software for consumer smart devices, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The privately-held...

at 14:36
Hospital Energy, the nation's leading energy firm for healthcare, announced it has rebranded as Environ Energy and has merged with Gotham 360, a renowned energy sustainability firm. Environ will offer best-in-class sustainability strategies and...

at 14:30
Ubyon, a Silicon Valley startup, today demonstrated a new enterprise cloud access solution as a Platinum launch partner of the AWS Cloud WAN service announced at AWS re:Invent hosted by Amazon Web Services (AWS). Ubyon's identity-asserted access...

News published on 1 october 2021 at 11:05 and distributed by: